Six presentations planned, including encore oral presentation of topline X-TOLE2 efficacy and safety results New poster will highlight the mechanistic characterization of azetukalner, including its potential additive effects when used with commonly prescribed ASMs VANCOUVER, BC and BOSTON, MA, Aug. 26, 2026 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused…
In people diagnosed with early-onset Alzheimer's disease, a biomarker tool that detects shrinkage of the brain's gray matter may predict how quickly someone may progress from mild cognitive impairment…
The Addis Ababa Call to Action: Protecting and Accelerating Multi-Disease Elimination in Africa elombatd@who.int Wed, 26/08/2026 - 21:04 addis-ababa-call-to-action.pdf (2.65 MB) Seventy-sixth session…
The NFL and NFL Players Association on Wednesday announced a Behavioral Health Network will launch on Sept. 1 and will be designed to provide simplified and confidential access to mental health…
